Gilead Sciences Inc (GILD) — closed signal from May 21, 2026
Target reached Published before the outcome was known, scored automatically when the window closed on August 19, 2026.
Predicted vs. what happened
GILD price · publication thesis → realized outcomesplit-adjusted
$124.36 – $129.29Entry zone — fair-value band
$129.08Published — price the day we called it
$148.75Target — the price the thesis aimed for
$148.97Peak — highest point inside the window, not a realized return
$147.60Window close — end-of-window price, context only
What happened
Target reached
Hit or exceeded the predicted growth inside the window.
Peak price
$148.97
peak on August 19, 2026 — not a realized returnPeak gain
+15.4%
peak, from the publication priceWindow close
$147.60
end-of-window price, context onlyDays to target
—
Window
May 21, 2026 – August 19, 2026
The thesis — published May 21, 2026
Predicted growth
+16%
over the measurement windowTarget price
$148.75
the price the thesis aimed forEntry zone
$124.36 – $129.29
the fair-value band we waited forPrice at publication
$129.08
published May 21, 2026Confidence
80%
how strongly the data lined upTimeframe
Short-term (0–3 months)
Gilead blends steady, defensive cash from its HIV franchise with reasonable valuation and reliable earnings. Growing free cash flow, a patent extension for Biktarvy, and an analyst upgrade have shifted the short-term story positively. After a heavy selloff the stock shows cleaner signs of stabilizing over the next few months compared with peers.
Primary drivers
- Biktarvy patent extension helps keep HIV sales steady over time
- Analyst upgrade improves short-term sentiment for the stock
- Consistent earnings and strong profit margins support cash flow
- Lower sensitivity to market swings adds defensive portfolio value
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Lyra
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.